Amit Singhal to Antitubercular Agents
This is a "connection" page, showing publications Amit Singhal has written about Antitubercular Agents.
Connection Strength
0.790
-
Cheng CY, B?hme J, Singhal A. Metabolic energy sensors as targets for designing host-directed therapies for tuberculosis. J Leukoc Biol. 2018 02; 103(2):215-223.
Score: 0.532
-
Haver HL, Chua A, Ghode P, Lakshminarayana SB, Singhal A, Mathema B, Wintjens R, Bifani P. Mutations in genes for the F420 biosynthetic pathway and a nitroreductase enzyme are the primary resistance determinants in spontaneous in vitro-selected PA-824-resistant mutants of Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2015 Sep; 59(9):5316-23.
Score: 0.112
-
Mani V, Wang S, Inci F, De Libero G, Singhal A, Demirci U. Emerging technologies for monitoring drug-resistant tuberculosis at the point-of-care. Adv Drug Deliv Rev. 2014 Nov 30; 78:105-17.
Score: 0.104
-
Pisu D, Huang L, Narang V, Theriault M, L?-Bury G, Lee B, Lakudzala AE, Mzinza DT, Mhango DV, Mitini-Nkhoma SC, Jambo KC, Singhal A, Mwandumba HC, Russell DG. Single cell analysis of M. tuberculosis phenotype and macrophage lineages in the infected lung. J Exp Med. 2021 09 06; 218(9).
Score: 0.043